摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenoxy-6-quinolinyl trifluoromethanesulfonate | 623144-20-7

中文名称
——
中文别名
——
英文名称
2-phenoxy-6-quinolinyl trifluoromethanesulfonate
英文别名
(2-phenoxyquinolin-6-yl) trifluoromethanesulfonate
2-phenoxy-6-quinolinyl trifluoromethanesulfonate化学式
CAS
623144-20-7
化学式
C16H10F3NO4S
mdl
——
分子量
369.321
InChiKey
JCMMUUBOIDYZGQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    464.6±45.0 °C(Predicted)
  • 密度:
    1.484±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    73.9
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-phenoxy-6-quinolinyl trifluoromethanesulfonate2-叔丁氧羰基氨基丙烯酸甲酯 在 palladium diacetate 四丁基氯化铵三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.5h, 以91%的产率得到methyl 2-[(tert-butoxycarbonyl)amino]-3-(2-phenoxy-6-quinolinyl)-2-propenoate
    参考文献:
    名称:
    [EN] 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS
    [FR] DERIVES DE 2,6-QUINOLINYLE ET DE 2,6-NAPHTYLE, LEURS PROCEDES DE PREPARATION ET LEUR UTILISATION COMME INHIBITEURS DE VLA-4
    摘要:
    本发明涉及式(I)的2,6-喹啉基和2,6-萘基衍生物,制备它们的方法,含有它们的药物组合物以及它们作为治疗VLA-4依赖性炎症性疾病的药物的用途,例如哮喘、过敏性鼻炎、鼻窦炎、结膜炎、食物过敏、牛皮癣、荨麻疹、瘙痒、湿疹、类风湿关节炎、炎症性肠病、多发性硬化和动脉粥样硬化等。式(I):其中X为N或CH。
    公开号:
    WO2003093237A1
  • 作为产物:
    描述:
    2-[(2,6-dichlorobenzoyl)oxy]-3-[2-(2,6-dichlorophenyl)-6-quinolinyl]propanoic acid 、 三氟甲磺酸酐吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 5.25h, 以87%的产率得到2-phenoxy-6-quinolinyl trifluoromethanesulfonate
    参考文献:
    名称:
    [EN] 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS
    [FR] DERIVES DE 2,6-QUINOLINYLE ET DE 2,6-NAPHTYLE, LEURS PROCEDES DE PREPARATION ET LEUR UTILISATION COMME INHIBITEURS DE VLA-4
    摘要:
    本发明涉及式(I)的2,6-喹啉基和2,6-萘基衍生物,制备它们的方法,含有它们的药物组合物以及它们作为治疗VLA-4依赖性炎症性疾病的药物的用途,例如哮喘、过敏性鼻炎、鼻窦炎、结膜炎、食物过敏、牛皮癣、荨麻疹、瘙痒、湿疹、类风湿关节炎、炎症性肠病、多发性硬化和动脉粥样硬化等。式(I):其中X为N或CH。
    公开号:
    WO2003093237A1
点击查看最新优质反应信息

文献信息

  • 2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors
    申请人:Lassoie Marie-Agnes
    公开号:US20080064720A1
    公开(公告)日:2008-03-13
    The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for the treatment of VLA-4 dependent inflammatory diseases such as for example asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and atherosclerosis. Formula (I): wherein X is N or CH.
    本发明涉及公式(I)的2,6-喹啉基和2,6-萘基衍生物,其制备方法,含有它们的制药组合物以及它们作为药物治疗VLA-4依赖性炎症性疾病的用途,例如哮喘、过敏性鼻炎、鼻窦炎、结膜炎、食物过敏、银屑病、荨麻疹、瘙痒、湿疹、类风湿性关节炎、炎症性肠病、多发性硬化和动脉粥样硬化。公式(I)中,X为N或CH。
  • 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS
    申请人:Lassoie Marie-Agnes
    公开号:US20100105681A1
    公开(公告)日:2010-04-29
    The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    本发明涉及2,6-喹啉基和2,6-萘基衍生物,其制备工艺,含有它们的制药组合物以及它们作为药物的用途。
  • 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
    申请人:UCB Pharma S.A.
    公开号:US07638630B2
    公开(公告)日:2009-12-29
    The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for the treatment of VLA-4 dependent inflammatory diseases such as for example asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and atherosclerosis. Formula (I): wherein X is N or CH.
    本发明涉及式(I)的2,6-喹啉基和2,6-萘基衍生物,其制备方法,含有它们的制药组合物以及它们作为治疗VLA-4依赖性炎症性疾病的药物的用途,例如哮喘、过敏性鼻炎、鼻窦炎、结膜炎、食物过敏、银屑病、荨麻疹、瘙痒、湿疹、类风湿性关节炎、炎症性肠病、多发性硬化和动脉硬化等。其中X为N或CH。
  • Coating composition for recording material and process for producing recording material
    申请人:OJI-YUKA SYNTHETIC PAPER CO., LTD.
    公开号:EP0887200A1
    公开(公告)日:1998-12-30
    A coating composition for a recording material and a process for producing the recording material are provided, wherein the coating composition includes an aluminum alkoxide, a binder and a hydrophilic solvent.
    提供了一种用于记录材料的涂层组合物和生产记录材料的工艺,其中涂层组合物包括氧化铝、粘合剂和亲水性溶剂。
  • Radiation-sensitive resin composition
    申请人:JSR Corporation
    公开号:EP1164433A1
    公开(公告)日:2001-12-19
    A positive-type radiation-sensitive resin composition is provided. The composition includes: (A) a low-molecular compound comprising a compound having at least one amino group having one or two hydrogen atom(s) bonded to the nitrogen atom; at least one hydrogen atom the amino group has having been substituted with a t-butoxycarbonyl group; (B) a radiation-sensitive acid generator; and (C) a silicon-atom-containing resin comprising an alkali-insoluble or alkali-slightly-soluble resin having been protected with an acid-cleavable group; the resin being capable of turning soluble in alkali upon cleavage of the acid-cleavable group. This radiation-sensitive resin composition is effectively responsive to radiations of various types, has superior sensitivity and resolution and also a superior long-term storage stability, and is useful as a positive-type chemically amplified resist.
    提供了一种正型辐射敏感树脂组合物。该组合物包括 (A) 一种低分子化合物,该化合物含有至少一个氨基,氨基上有一个或两个氢原子与氮原子结合;氨基上的至少一个氢原子被一个叔丁氧羰基取代; (B) 辐射敏感酸发生器;以及 (C) 含硅原子的树脂,该树脂由碱不溶性或碱微溶性树脂组成,并用酸可裂解基团保护;该树脂在酸可裂解基团裂解后可溶于碱。这种辐射敏感树脂组合物能有效地对各种类型的辐射做出反应,具有极高的灵敏度和分辨率,以及极佳的长期储存稳定性,可用作正型化学放大抗蚀剂。
查看更多